Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Liabilities and Shareholders Equity (2022 - 2026)

Updated

Analysis

Adaptin Bio (APTN) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Adaptin Bio 56.76 Mn 54.75 Mn - 981,452.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 981,452.00
Mar 31, 2026 706,117.00
Dec 31, 2025 619,159.00
Sep 30, 2025 979,474.00
Jun 30, 2025 1.66 Mn
Mar 31, 2025 2.85 Mn
Dec 31, 2024 239,415.00
Sep 30, 2024 322.00
Jun 30, 2024 322.00
Mar 31, 2024 380.00
Dec 31, 2023 380.00
Sep 30, 2023 380.00
Dec 31, 2022 500.00
API Access

Adaptin Bio Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=APTN&period=max&api_key=YOUR_API_KEY